News stories about Dynatronics (NASDAQ:DYNT) have trended somewhat positive this week, Accern Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Dynatronics earned a daily sentiment score of 0.08 on Accern’s scale. Accern also assigned news stories about the medical equipment provider an impact score of 45.39872448679 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

These are some of the media headlines that may have effected Accern Sentiment Analysis’s scoring:

Separately, Zacks Investment Research downgraded shares of Dynatronics from a “hold” rating to a “sell” rating in a report on Tuesday, September 12th.

Dynatronics (NASDAQ DYNT) traded down $0.04 during trading on Wednesday, reaching $3.20. 29,000 shares of the company’s stock traded hands, compared to its average volume of 34,067. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.46 and a quick ratio of 0.92. The company has a market capitalization of $15.75, a P/E ratio of -2.86 and a beta of -0.09. Dynatronics has a 1-year low of $2.10 and a 1-year high of $3.75.

Dynatronics (NASDAQ:DYNT) last posted its quarterly earnings results on Tuesday, November 14th. The medical equipment provider reported $0.00 earnings per share for the quarter, topping the consensus estimate of ($0.08) by $0.08. The business had revenue of $12.80 million during the quarter. Dynatronics had a negative net margin of 3.42% and a negative return on equity of 45.78%. analysts predict that Dynatronics will post -0.09 earnings per share for the current year.

In related news, Director Brian Larkin purchased 40,000 shares of Dynatronics stock in a transaction that occurred on Thursday, November 30th. The shares were bought at an average price of $2.50 per share, for a total transaction of $100,000.00. Following the completion of the transaction, the director now directly owns 80,276 shares of the company’s stock, valued at $200,690. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, major shareholder Ventures 1 Lp Provco purchased 300,000 shares of Dynatronics stock in a transaction that occurred on Thursday, November 30th. The shares were bought at an average price of $2.50 per share, for a total transaction of $750,000.00. Following the transaction, the insider now directly owns 586,944 shares of the company’s stock, valued at $1,467,360. The disclosure for this purchase can be found here. Over the last ninety days, insiders have bought 369,015 shares of company stock valued at $930,372. Insiders own 51.80% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This report was first published by Watch List News and is the sole property of of Watch List News. If you are viewing this report on another website, it was copied illegally and reposted in violation of U.S. and international copyright and trademark law. The original version of this report can be read at

About Dynatronics

Dynatronics Corporation is a manufacturer and distributor of physical medicine products. The Company’s products include a line of medical equipment for physical medicine applications, including therapy devices, medical supplies and soft goods, treatment tables and rehabilitation equipment. Its products are used by physical therapists, chiropractors, sports medicine practitioners, podiatrists, physicians and other physical medicine professionals.

Insider Buying and Selling by Quarter for Dynatronics (NASDAQ:DYNT)

Receive News & Ratings for Dynatronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics and related companies with's FREE daily email newsletter.